Stericycle, Inc. (NASDAQ:SRCL) Shares Sold by Mondrian Investment Partners LTD

Mondrian Investment Partners LTD cut its stake in shares of Stericycle, Inc. (NASDAQ:SRCL - Free Report) by 97.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,894 shares of the business services provider's stock after selling 912,730 shares during the period. Mondrian Investment Partners LTD's holdings in Stericycle were worth $1,282,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Capital Research Global Investors raised its holdings in shares of Stericycle by 13.4% during the fourth quarter. Capital Research Global Investors now owns 5,987,937 shares of the business services provider's stock valued at $296,762,000 after acquiring an additional 705,586 shares in the last quarter. First Eagle Investment Management LLC raised its stake in Stericycle by 5.2% during the 1st quarter. First Eagle Investment Management LLC now owns 242,975 shares of the business services provider's stock valued at $12,817,000 after purchasing an additional 12,000 shares during the period. Robeco Institutional Asset Management B.V. bought a new stake in Stericycle during the 4th quarter valued at approximately $156,000. Illinois Municipal Retirement Fund bought a new stake in Stericycle during the 1st quarter valued at approximately $756,000. Finally, Sei Investments Co. increased its stake in Stericycle by 5.9% in the 1st quarter. Sei Investments Co. now owns 1,124,481 shares of the business services provider's stock worth $59,316,000 after acquiring an additional 63,112 shares during the last quarter. 98.82% of the stock is currently owned by institutional investors.

Stericycle Trading Up 0.0 %

Shares of Stericycle stock traded up $0.02 during trading hours on Wednesday, hitting $61.70. The company's stock had a trading volume of 1,811,549 shares, compared to its average volume of 1,104,755. The stock has a market cap of $5.73 billion, a price-to-earnings ratio of -280.45, a P/E/G ratio of 3.37 and a beta of 1.11. Stericycle, Inc. has a twelve month low of $37.78 and a twelve month high of $61.77. The firm has a fifty day moving average of $59.13 and a 200-day moving average of $54.67. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.13 and a current ratio of 1.13.

Stericycle (NASDAQ:SRCL - Get Free Report) last issued its quarterly earnings results on Thursday, July 25th. The business services provider reported $0.61 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.57 by $0.04. Stericycle had a net margin of 1.37% and a return on equity of 7.94%. The company had revenue of $661.60 million for the quarter, compared to analyst estimates of $672.07 million. Research analysts forecast that Stericycle, Inc. will post 2.29 EPS for the current year.

Analysts Set New Price Targets

SRCL has been the subject of a number of recent research reports. Keefe, Bruyette & Woods lifted their target price on Stericycle from $135.00 to $142.00 and gave the stock an "outperform" rating in a report on Tuesday, June 4th. Royal Bank of Canada reiterated a "sector perform" rating and issued a $62.00 target price (down previously from $69.00) on shares of Stericycle in a report on Tuesday, June 4th. Truist Financial lifted their target price on Stericycle from $50.00 to $62.00 and gave the stock a "hold" rating in a report on Tuesday, June 4th. Finally, StockNews.com started coverage on Stericycle in a report on Tuesday. They set a "hold" rating for the company. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $74.00.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.